Anti-Ocrelizumab Polyclonal Antibody from ProteoGenix; catalogue ARO-A19193; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-ocrelizumab antibodies are used in research to detect and analyze ocrelizumab in biological samples. These antibodies are commonly applied in studies focused on antibody characterization and assay development.
Ocrelizumab is a monoclonal antibody targeting CD20, widely studied in immunology and therapeutic antibody research. Analytical tools such as anti-ocrelizumab antibodies are essential for detection and monitoring purposes in laboratory settings.
This product belongs to our range of polyclonal antibodies and complements our catalog of monoclonal antibodies for research and analytical applications. Additional tools such as ELISA assay kits can be used for quantitative detection workflows.
If your research requires specific binding properties or assay performance, our custom antibody solutions can support your project from discovery to characterization.
For more advanced needs, our antibody discovery and antibody characterization services can help develop and validate antibodies adapted to your application.
ProteoGenix catalogue number ARO-A19193. For research use only.
Target: Ocrelizumab; Host: Rabbit; Clonality: Polyclonal Antibody; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Ocrelizumab |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
